Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
boston blog main
clinical trials
2
×
life sciences
national blog main
national top stories
2
×
new york blog main
new york top stories
startups
venture capital
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
antisense oligonucleotide
astrazeneca
benzodiazepines
blackstone group
blackstone life sciences
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
columbia university
covid-19
crispr
david goldstein
deals
deerfield management
depression
detroit blog main
detroit top stories
What
ceo
medicines
2
×
acquisitions
aims
announced
backed
bio
cause
collabs
covid
daniel
deal
drugs
epilepsy
genes
genetic
gilead
gilead’s
help
introduce
ipo
links
marcio
month
mutations
neuro
new
o’day
plans
praxis
precision
research
roundup
sciences
souza
stop
transformative
turn
years
Language
unset
Current search:
biogen
×
medicines
×
" clinical trials "
×
" national top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More